Cases 1 - 10 of 13
Bausch Health Ireland Limited et al v. Mylan Laboratories Ltd. et al
as 1:2021cv00611
Plaintiff:
Bausch Health Ireland Limited and Salix Pharmaceuticals, Inc.
Defendant:
Agila Specialties Inc., Mylan Pharmaceuticals Inc., Mylan Inc. and others
Cause Of Action: 35 U.S.C. § 1
Salix Pharmaceuticals, Ltd. et al v. Norwich Pharmaceuticals, Inc.
as 1:2020cv00430
Defendant:
Alvogen PB Research And Development LLC, Norwich Pharmaceticals, Inc. and Norwich Pharmaceuticals Inc.
Plaintiff:
Salix Pharmaceuticals, Inc., Bausch Health Ireland Ltd., Salix Pharmaceuticals, Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Salix Pharmaceuticals Ltd. et al v. Sun Pharmaceuticals Industries Ltd.
as 1:2019cv00734
Plaintiff:
Salix Pharmaceuticals Ltd., Alfasigma S.p.A., Salix Pharmaceuticals, Inc. and others
Defendant:
Sun Pharmaceuticals Industries Ltd.
Cause Of Action: 35 U.S.C. § 271
Bausch Health Ireland Limited et al v. Lupin Ltd. et al
as 1:2019cv00626
Plaintiff:
Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. and Norgine B.V.
Defendant:
Lupin Ltd., Lupin Inc., Lupin Pharmaceuticals, Inc. and others
Cause Of Action: 35 U.S.C. § 271
Salix Pharmaceuticals, Inc. et al v. Teva Pharmaceuticals USA, Inc.
as 1:2017cv00329
Plaintiff:
Salix Pharmaceuticals, Inc. and Dr. Falk Pharma GmbH
Defendant:
Teva Pharmaceuticals USA, Inc.
Counter_claimant:
Teva Pharmaceuticals USA, Inc.
Counter_defendant:
Dr. Falk Pharma GmbH and Salix Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Salix Pharmaceuticals, Ltd. et al v. Actavis Laboratories FL, Inc.
as 1:2016cv00188
Plaintiff:
Salix Pharmaceuticals, Ltd. , Salix Pharmaceuticals, Inc. , Valeant Pharmaceuticals Luxembourg S.A.R.L. and others
Defendant:
Actavis Laboratories FL, Inc.
Cause Of Action: 35 U.S.C. § 271
Salix Pharmaceuticals, Inc. et al v. Taro Pharmaceuticals U.S.A., Inc. et al
as 1:2015cv00900
Plaintiff:
Salix Pharmaceuticals, Inc. and Norgine B.V.
Defendant:
Taro Pharmaceuticals U.S.A., Inc. and Taro Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271
Salix Pharmaceuticals, Inc. et al v. Apotex, Inc. et al
as 1:2015cv00880
Plaintiff:
Salix Pharmaceuticals, Inc. , Glycyx Pharmaceuticals, Ltd. , Valeant Pharmaceuticals International and others
Defendant:
Apotex, Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271
Salix Pharmaceuticals Inc. et al v. Novel Laboratories Inc.
as 1:2015cv00027
Plaintiff:
Salix Pharmaceuticals Inc. and Dr. Falk Pharma GmbH
Defendant:
Novel Laboratories Inc.
Counter_claimant:
Novel Laboratories Inc.
Counter_defendant:
Dr. Falk Pharma GmbH and Salix Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Salix Pharmaceuticals Ltd. et al v. Mylan Pharmaceuticals Inc.
as 1:2014cv01055
Plaintiff:
Salix Pharmaceuticals Ltd. , Salix Pharmaceuticals Inc. and Glycyx Pharmaceuticals Ltd.
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
